http://www.w3.org/ns/prov#value | - Among the Company's recent product initiatives is a measure to expand its presence in cardiovascular diagnostic and therapeutic devices, one of the fastest-growing segments of the biomedical industry, with an expected value of nearly $28 billion before the end of this decade.
|